Intracerebral metastases other imaging findings

Intracerebral metastases Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Intracerebral Metastases from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Intracerebral metastases other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Intracerebral metastases other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Intracerebral metastases other imaging findings
CDC on Intracerebral metastases other imaging findings
Intracerebral metastases other imaging findings in the news
Blogs on Intracerebral metastases other imaging findings
Directions to Hospitals Treating Intracerebral metastases
Risk calculators and risk factors for Intracerebral metastases other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other imaging tests for intracerebral metastases include magnetic resonance spectroscopy (intratumoural choline and lipid peak with depleted N-acetylaspartate), magnetic resonance perfusion (reduced cerebral blood volume and cerebral blood flow in the region of metastasis), and positron emission tomography (hypermetabolic, hypometabolic, or variable metabolism depending on the primary).

Other Imaging Findings

Magnetic Resonance Spectroscopy

• MR spectroscopy may be helpful in the diagnosis of intracerebral metastases.
• Findings on MR spectroscopy include:

• Intratumoral choline peak with no choline elevation in the peritumoral edema
• Any tumor necrosis results in a lipid peak
• N-acetylaspartate (NAA) depleted

Magnetic Resonance Perfusion

• MR perfusion demonstrates reduced CBV (cerebral blood volume) and CBF (cerebral blood flow) in the region of metastasis. Surrounding edema demonstrates normal CBV.

Gallery

• 

  _{MR perfusion of brain of a known case of renal cell carcinoma demonstrates reduced CBV (cerebral blood volume) and CBF (cerebral blood flow) in the region of metastasis. Surrounding edema demonstrates normal CBV.}

• 

  _{MR perfusion of brain of a case of renal cell carcinoma demonstrates highly variable appearance of hemorrhagic metastases to the brain.}

Positron Emission Tomography

1. Fludeoxyglucose F 18-positron emission tomography (FDG-PET)

• Fludeoxyglucose F 18-positron emission tomography is generally considered as the best imaging tool for metastases.
• However, it can only detect metastases upto 1.5 cm in size, therefore contrast MRI remains the gold standard to rule out small metastases. Lung, breast, colorectal, head and neck, melanoma, and thyroid metastases are usually hypermetabolic.
• Mucinous adenocarcinoma and renal cell carcinoma are typically hypometabolic.
• Gliomas and lymphomas are variable.
• Any central hypometabolism indicates necrosis.

2. Positron emission tomography/computed tomography (PET/CT)

• PET/CT may have higher sensitivity in detecting metastases, partly due to hybrid imaging part, computed tomography (CT).
• It may even demonstrate asymptomatic metastases in patients examined for extracranial disease.

References

Template:WikiDoc Sources